within April Organised by the With
|
|
- Kristina Norris
- 6 years ago
- Views:
Transcription
1 EFGCP Multi-Stakeholder Workshop & Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member States 13 April 2016 MCE Conference Centre Brussels, Belgium Organised by the European Forum for Good Clinical Practice With the Partnerships -
2 Introduction EFGCP Workshop on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? 13 April 2016, MCE Conference Centre, Brussels, Belgium - Final Programme A revision of the Clinical Trials Regulation has been adopted by European legislation makers in This revised legal framework will bring significant advances compared to todays situation and is expected to be fully implemented as soon as the supporting Clinical Trials Portal and Database are fully functional (2H2017). The opportunity of the new Regulation to improve harmonisation and competitiveness of clinical research in Europe while safeguarding patients interests must be fully carried through at the national level to enable our region to emerge as an attractive place for conducting Clinical Research. This will not only benefit commercial and non-commercial sponsors, but specifically patients who are eagerly waiting to participate in Clinical Trials and benefit from new treatment options. The new legal rules specifically mandate a closer co-ordination of clinical trial applications assessments across EU Member States, supported by much closer collaboration between the national competent authorities and the ethics committees within each Member State. EFGCP had hosted an initial workshop in September 2014 to discuss key implementation aspects with patients, academia, ethics committees, regulators and industry and share some good ideas and best practices to swiftly start the process in each country. This follow-on workshop aims now to show case the tremendous progress that has been made with the implementation over the past 18 months. The European Commission, for example, is facilitating discussions to resolve some key harmonisation questions across Europe. The EMA has made significant progress with the development of the new EU Clinical Trials Database and Portal which is the key working tool to facilitate a streamlined and swift coordination process between the various parties involved. In addition, Member States have started to develop new local procedures and initiated some early pilots to test the new assessment scenario. And finally Ethics Committees are intensifying or starting up new collaborations across countries to discuss important aspects of harmonisation of assessment criteria, methodologies and training of reviewers. Programme Committee Ingrid Klingmann Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium Kim Champion Hugh Davies Sini Eskola Jozef Glasa Angelika Joos Anastassia Negrouk University College London (UCL), EFGCP, United Kingdom Health Research Authority (HRA), United Kingdom European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia Merck Sharp & Dohme, Belgium European Organisation for Research and Treatment of Cancer (EORTC), Belgium Faculty Péter Arányi Hungarian Ethics Committee for Clinical Pharmacology, Hungary Cristina Avendaño Solá Hospital Puerta de Hierro Majadahonda, Spain Kim Champion University College London (UCL), EFGCP, United Kingdom Giulio Corbelli European AIDS Treatment Group (EATG), Italy Marek Czarkowski Centre for Bioethics of Supreme Medical Council, Poland Hugh Davies Health Research Authority (HRA), United Kingdom Sini Eskola European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium Jozef Glasa Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia Maja Leon Grzymkowska DG Health, European Commission Joerg Hasford Ludwig-Maximilians-University of Munich, Germany Kaisa Immonen- European Patients Forum (EPF), Belgium Charalambous Angelika Joos Merck Sharp & Dohme, Belgium Page 2 of 5
3 13 April 2016, MCE Conference Centre, Brussels, Belgium - Final Programme Ingrid Klingmann François Lemaire Greet Musch Anastassia Negrouk Fabien Peuvrelle Claire Sibenaler Ernst Singer Fergus Sweeney Nick Sykes Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium Hôpital Henri-Mondor, Délégation Interrégionale à la Recherche Clinique (DIRC), France Federal Agency for Medicines and Health Products, Belgium European Organisation for Research and Treatment of Cancer (EORTC), Belgium Celgene, Switzerland Les Entreprises du Médicament (LEEM), France Ethics Committee of the Medical University of Vienna, Austria European Medicines Agency (EMA) Pfizer, United Kingdom Workshop Venue MCE Conference Centre Rue de l'aqueduc, Ixelles Belgium Tel: Website: Workshop Language The language of the workshop will be English. Registration & Information OPEN EVENT - conferences@efgcp.eu or visit Page 3 of 5
4 13 April 2016, MCE Conference Centre, Brussels, Belgium Final Programme Agenda Wednesday 13 th April 09:00 Registration & Welcome Coffee 09:30 Welcome, General Introduction & Aim of the Day Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium SESSION 1: General Status of the Regulation Implementation Chairs: Angelika Joos, Merck Sharp & Dohme, Belgium & Giulio Corbelli, European AIDS Treatment Group (EATG), Italy 09:40 Keynote: Where do we stand with the implementation in Europe? Maja Leon Grzymkowska, DG Health, European Commission - What are the key questions for harmonization? - What is the implementation date? 09:55 Presentation of the Portal and Database and how it enables cooperation in the assessment and decision making process Fergus Sweeney, European Medicines Agency (EMA) - Where does the portal development stand? - How does the assessment process look in the system? - How are the various stakeholders participating? 10:25 Implementation across Europe: Summary from the EFPIA CTiMonitor quarterly survey Sini Eskola, European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium 11:00 Coffee Break SESSION 2: Member State progress and early pilots Chairs: Hugh Davies, Health Research Authority (HRA), United Kingdom & Kim Champion, University College London (UCL), EFGCP, United Kingdom 11:20 The Future Approach to clinical trial application assessment How to coordinate a swift assessment? Presentations from: - Joerg Hasford,Ludwig-Maximilians-University of Munich,Germany - François Lemaire, Hôpital Henri-Mondor, Délégation Interrégionale à la Recherche Clinique (DIRC), France - Greet Musch, Federal Agency for Medicines and Health Products, Belgium Followed by Q&A discussion with the audience 12:45 Lunch Break Page 4 of 5
5 13 April 2016, MCE Conference Centre, Brussels, Belgium Final Programme Chairs: Anastasia Negrouk, European Organisation for Research and Treatment of Cancer (EORTC), Belgium & Fabien Peuvrelle, Celgene, Switzerland 13:45 The Future Approach to clinical trial application assessment How to coordinate a swift assessment? Presentations from: - Péter Arányi,Hungarian Ethics Committee for Clinical Pharmacology, Hungary (remote presentation) - Cristina Avendaño Solá, Hospital Puerta de Hierro Majadahonda, Spain - Marek Czarkowski, Centre for Bioethics of Supreme Medical Council, Poland Followed by Q&A discussion with the audience 15:10 Coffee Break SESSION 3: What else must be done to facilitate collaboration? Chairs: Jozef Glasa, Slovak Medical University/Institute of Medical Ethics & Bioethics, European Forum for Good Clinical Practice (EFGCP), Slovakia & Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium 15:30 Panel discussion about pilot experience, ethic committee collaborations, sharing of best practices, training of assessors Panelists: Kaisa Immonen-Charalambous, European Patients Forum (EPF), Belgium Ernst Singer, Ethics Committee of the Medical University of Vienna, Austria Claire Sibenaler, Les Entreprises du Médicament (LEEM), France Nick Sykes, Pfizer, United Kingdom 16:55 Conclusions & Next Steps Ingrid Klingmann, Pharmaplex, European Forum for Good Clinical Practice (EFGCP), Belgium 17:00 End of Workshop Page 5 of 5
within April Organised by the
EFGCP Multi-Stakeholder Workshop &Discussion on How to Ensure Optimal Ethical Review within the New Clinical Trials Regulation? Wheree do we currently stand with the implementation in different Member
More informationOptions and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal
EFGCP Workshop on Options and Challenges for Ethical Assessment in the Clinical Trial Regulation Proposal Road Map Initiative for Clinical Research in Europe Husa President Hotel, Brussels, Belgium 7 &
More informationA Multi-Stakeholder Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on
A Multi-Stakeholder Workshop of the Joint EFGCP-MedTech Europe Medical Technology Working Party on Mitigating Risks in the Lifecycle of Medical Devices: Options and Challenges in Building Clinical Evidence
More informationExplore Ways to Enhance Collaboration Between Key Players
Joint EFGCP / DIA / EMA Better Medicines for Children Conference 2014 on Explore Ways to Enhance Collaboration Between Key Players 30 th September & 1 st October 2014 EMA, London, United Kingdom Organised
More informationEUPATI 2013 CONFERENCE EUPATI: A VISION FOR 2020
EUPATI 2013 CONFERENCE EUPATI: A VISION FOR 2020 19 April 2013, Hilton Rome Airport Hotel, Rome Airport Fiumicino, Italy Introduction The EUPATI consortium is delighted to announce its first EUPATI conference
More informationNETWORKING OF EUROPEAN REC`S. Dirk Lanzerath EUREC, Secretary General
NETWORKING OF EUROPEAN REC`S Dirk Lanzerath EUREC, Secretary General First steps of EUREC based on 2001 EC Directive on good clinical practice in the conduct of clinical trials on medicinal products for
More informationTaking forward reform of the EU Clinical Trials Directive. Introduction
Taking forward reform of the EU Clinical Trials Directive Introduction Implementation of the Clinical Trials Directive (CTD), intended to harmonise authorisation of EU clinical trials on medical products,
More informationBiomarkers and Patient s Access to Personalized Oncology Drugs in Europe
CDDF Cancer Drug Development Forum CDDF MULTI - STAKEHOLDER WORKSHOP Biomarkers and Patient s Access to Personalized Oncology Drugs in Europe Brussels, Belgium 24-25 September 2018 PROGRAMME PROGRAMME
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 18 th International Conference on Medicinal and Pharmaceutical Chemistry October 18-19, 2018, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote
More informationUpdate on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network
Update on the IMI2 Proposal to Build a Sustainable pan- European Paediatric Clinical Trials Network William R Treem, M.D.;* Child Health Innovation and Leadership Department, Johnson and Johnson October
More informationENVIRONMENTAL RISK ASSESSMENTS: EU CLINICAL TRIALS WITH GMO-BASED ATMPS ANN GORMAN, AMGEN LTD, UK 16 DECEMBER 2016
ENVIRONMENTAL RISK ASSESSMENTS: EU CLINICAL TRIALS WITH GMO-BASED ATMPS ANN GORMAN, AMGEN LTD, UK 16 DECEMBER 2016 SIMPLIFIED DEFINITIONS Genetically Modified Organism (GMO)? An organism, e.g virus, plant,
More informationSession 13: Prequalification Within the Context of Global Fund Procurements
Session 13: Prequalification Within the Context of Global Fund Procurements Established in 2002 Global Fund Attracts and disburses additional resources to prevent and treat AIDS, tuberculosis (TB), and
More informationEuropean Pharmaceutical Policy: Access for Patients or Improving Competitiveness
European Pharmaceutical Policy: Access for Patients or Improving Competitiveness The s Vision Dr Stefaan Van der Spiegel Policy Officer, Unit F5 DG Enterprise and Industry Study day OSE / RIZIV-INAMI Brussels,
More informationEMA/HMA/EC workshop on electronic Product Information (epi)
EMA/HMA/EC workshop on electronic Product Information (epi) Improving access to the EU medicines product information Wednesday, 28 November 2018 European Medicines Agency London, United Kingdom Background
More informationEU Innovation Network
EMA Roundtable Meeting, London, 27 November, 2015 >>www.pei.de EU Innovation Network Federal Agency for Vaccines and Biomedicines Bettina Ziegele - Start 2001: ITF at EMA 2008-2011: first innovation offices
More informationReview of EU Clinical Trial Directive. 15 May 2012 Mike Beckers Sidley Austin LLP, Brussels
BEIJING BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE SYDNEY TOKYO WASHINGTON, D.C. Review of EU Clinical Trial Directive 15
More informationMaking the case for Personalised Medicine
Making the case for Personalised Medicine The biopharmaceutical industry perspective Barbara Freischem Executive Director European Biopharmaceutical Enterprises Who we are EBE represents the voice of biopharmaceutical
More informationA regulatory update in a day for Small to Medium-sized Enterprises
TOPRA ANNUAL SYMPOSIUM STOCKHOLM, SWEDEN In partnership with the Swedish Medical Products Agency Time of transformation: Implementing international regulatory change A regulatory update in a day for Small
More informationThe FMD Pack Coding, Sharing and Transition
The FMD Pack Coding, Sharing and Transition Ask the expert Joan Cahill & Grant Courtney April 2017 Introduction Joan Cahill Director, Pfizer Packaging & Delivery Systems Member EFPIA Supply Chain Working
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 9 th World Congress on Bioavailability & Bioequivalence April 16-18, 2018 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme aims
More informationMechanism of coordinated access to Orphan Medicinal Products. MoCA. NIHDI Belgium
Mechanism of coordinated access to Orphan Medicinal Products MoCA dr Ri DeRidder NIHDI Belgium Context The Issue: Delays and disparities in access to OMP s Decisions on Pricing and Reimbursement exclusive
More informationEUCERD RECOMMENDATION FOR A
EUCERD RECOMMENDATION FOR A CAVOMP INFORMATION FLOW RECOMMENDATION OF THE EUROPEAN UNION COMMITTEE OF EXPERTS ON RARE DISEASES TO THE EUROPEAN COMMISSION AND THE MEMBER STATES ON IMPROVING INFORMED DECISIONS
More informationPediatric drug development - do we need a PIP so early in development? American versus European approach
Pediatric drug development - do we need a PIP so early in development? American versus European approach Angelika Joos Executive Director, Global Regulatory Policy Merck Sharp & Dohme (Europe) Inc., Brussels
More informationLEO Pharma Commercial Excellence EU+
LEO Pharma Commercial Excellence EU+ Geomarketing Praxistag Health 12. März 2018 Karsten Schmidt, Director Commercial Excellence, LEO Pharma March 12, 2018 Commercial Excellence Karsten Schmidt, LEO Pharma
More informationMODULE 12 Regulatory affairs April 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES
MODULE 12 Regulatory affairs 26-27 April 2017 POST-GRADUATE PROGRAMME IN PHARMACEUTICAL MEDICINE & MEDICINES DEVELOPMENT SCIENCES n DRUG REGISTRATION : EUROPEAN PROCEDURES AND INTERNATIONAL ENVIRONMENT
More informationEU-RUSSIA ENERGY DIALOGUE
EU-RUSSIA ENERGY DIALOGUE Thematic Group on Energy Efficiency REPORT 2010 (SECOND HALF 2008 SECOND HALF 2010) INTRODUCTION Cooperation on energy efficiency, energy savings and renewable energy is an important
More informationResearch Ethics Committees and Ethical Review in Europe
Multidisciplinary Workshop on Research Ethics Committees and Ethical Review in Europe 19 th January 2010, Barcelona, Spain On behalf of the Road Map Initiative for Clinical Research in Europe FINAL REPORT
More informationClinical Trials Environment EU Legislation: Ausblick auf die neue Gesetzgebung für klinische Prüfungen
The Future of the Regulatory Berlin, 31.05.2013 Clinical Trials Environment EU Legislation: Qualifizierungstag für Study Nurses Ausblick auf die neue Gesetzgebung für klinische Prüfungen Dr. med. Ingrid
More information26 June 2017 Maison des Associations Internationales rue Washington, 40 B-1050 Bruxelles, Belgium
EU-funded Project Capacity4Rail Interactive Workshop A New Competitive, Reliable, Sustainable and Connected Rail Freight Transport rue Washington, 40 Detailed Programme & Practical Information An event
More informationGlobal Clinical Trials Transparency Conference September 2018
Global Clinical Trials Transparency Conference 19-20 September 2018 Pre-Conference Workshop : The Evolving Disclosure/Transparency Landscape 18 September 2018 Doubletree by Hilton Docklands Riverside London,
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 29.06.2005 COM(2005) 286 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE COMMITTEE OF THE REGIONS AND THE EUROPEAN ECONOMIC
More informationEUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL
EUROPEAN COMMISSION HEALTH AND FOOD SAFETY DIRECTORATE-GENERAL Health systems, medical products and innovation Medicines: policy, authorisation and monitoring PHARM 723 PHARMACEUTICAL COMMITTEE 18 October
More informationINTERNATIONAL CONFERENCE. Socio-economic Impacts of Biofuels and Bio-products
INTERNATIONAL CONFERENCE Socio-economic Impacts of Biofuels and Bio-products Final Conference of the Global-Bio-Pact Project Brussels - Belgium 29-30 January 2013 Programme (Status: 29 November 2012) Conference
More informationMinutes of the ninth meeting of the EMA Human Scientific Committees Working Party with Patients' and Consumers' Organisations (PCWP)
17 March 2010 EMA/625710/2009 Minutes of the ninth meeting of the EMA Human Scientific Committees Working Party with Patients' and Consumers' Organisations (PCWP) 30 September 2009 Role Chairpersons: Present:
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES 10 th International Tissue Repair and Regeneration Congress June 13-14, 2019 Helsinki, Finland our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our programme
More informationPublic Consultation on the European Solidarity Corps
Contribution ID: 2d9b4621-cc4d-4c64-a5af-13acac98b4fe Date: 31/03/2017 17:04:55 Public Consultation on the European Solidarity Corps Fields marked with * are mandatory. Introduction The European Solidarity
More informationPublic - Private Partnerships in Europe and ENCePP Initiative
Public - Private Partnerships in Europe and ENCePP Initiative Henry Fitt Section Head, Co-ordination & Networking, Pharmacovigilance and Risk Management European Medicines Agency 22nd Annual EuroMeeting
More informationCMC Strategy Forum Prague Enda Moran EBE Satellite Session, 06 May 2013
CMC Strategy Forum Prague 2013 Enda Moran EBE Satellite Session, 06 May 2013 European Biopharmaceutical Enterprises EBE s VISION: fostering innovation, and promote favorable business and regulatory conditions
More informationPersonalised Medicine Conference 2016
Personalised Medicine Conference 2016 1-2 June 2016, Brussels Ruxandra DRAGHIA-AKLI European Union, 2016 Image sources: Raman Khilchyshyn #70301568, Anthonyc #78062504, robu_s #90937022, Kamaga #774676758,
More informationConference programme Results-based Agri-environment Schemes: payments for biodiversity achievements in agriculture Brussels, September 2014
Conference programme Results-based Agri-environment Schemes: payments for biodiversity achievements in agriculture Brussels, 23 24 September 2014 #rbaps Background This conference forms part of the study,
More informationWP Inspection Competence of Authorities
WP Inspection Competence of Authorities Eva G. Friberg (chair) and Steve Ebdon-Jackson 1 Action Plan Tasks: Survey on clinical competence 2012 Clinical training courses for Inspectors in UK 2014 HERCA
More informationE O. The EORTC Strategy for New Drug Development THE EORTC PROVIDES: The EORTC is the leading pan-european partner for high-quality clinical research
The EORTC Strategy for New Drug Development The EORTC is the leading pan-european partner for high-quality clinical research E O RT C THE EORTC PROVIDES: A NETWORK OF HIGH-QUALITY, DEDICATED CLINICAL RESEARCHERS
More informationCredit Guarantee Schemes: Regulation and Management
PUTTING IN PLACE THE CONDITIONS TO SET UP A CREDIT GUARANTEE SCHEME FOR AGRIBUSINESS SMEs IN UKRAINE Credit Guarantee Schemes: Regulation and Management Capacity Building Seminars 22-24 February 2016 Ministry
More informationInformation points report
ESCO (2015) SEC 073 FINAL Creation Date: 16/07/2015 Last update: 15/09/2015 Information points report Purpose of the document The purpose of this document is to brief the ESCO Maintenance Committee (MAI)
More informationTransport & Climate Change - European Researchers Act
Transport & Climate Change - European Researchers Act A workshop organised by ETRA - European Transport Research Alliance & IFSTTAR - Institute of Science and Technology for Transport, Development and
More informationWRITTEN SUBMISSION ON THE OPERATION OF THE CLINICAL TRIALS DIRECTIVE (DIRECTIVE 2001/20/EC) AND PERSPECTIVES FOR THE FUTURE
WRITTEN SUBMISSION ON THE OPERATION OF THE CLINICAL TRIALS DIRECTIVE (DIRECTIVE 2001/20/EC) AND PERSPECTIVES FOR THE FUTURE ECRIN (European Clinical Research Infrastructures Network) EORTC (European Organization
More informationENVIRONMENT. Achieving CONCEPT PAPER
ASIA SIA-EUROPE ENVIRONMENT FORUM 5 TH ROUNDTABLE Achieving Urban Sustainability: Integrated Environmental Management 28-30 November Shenzhen, China CONCEPT PAPER SUMMARY A roundtable discussion among
More informationEEA resource efficiency webinar, 4 Dec 2015
EEA resource efficiency webinar, 4 Dec 2015 More from less and 2015 review of material resource efficiency policies in 31 countries Welcome - will start at 12:30 sharp Here you can adjust the size of display
More information4th annual LONDON SPONSORSHIP BROCHURE. Get in touch with James Taylor to discuss bespoke packages -
4th annual LONDON SPONSORSHIP BROCHURE Get in touch with James Taylor to discuss bespoke packages - jtaylor@fintecnet.com Focus for RBI EU 2019 In 2019, RBI EU 2018 will continue to focus on the digital
More informationTechnical assistance tools and public support schemes to exploit resource efficiency potential in SMEs
Technical assistance tools and public support schemes to exploit resource efficiency potential in SMEs Tuesday 22nd May 2018 Ministry of Industry and Trade, Prague, Czech Republic ABOUT THE WORKSHOP Event
More informationActivities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of Korea
Activities of the Korean Association of the Institutions Review Boards (KAIRB) in the year of 2002-2003 Korea October 18, 2003 Ock-Joo Kim, M.D., Ph.D. General Secretary of KAIRB (Seoul, Korea) I. Foundation
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL PUBLIC CONSULTATION
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Healthcare systems Health systems and products PUBLIC CONSULTATION Brussels, 31 July 2012 on the modalities of stakeholder consultation in the
More informationEHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES. Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium
EHR4CR DEPLOYING INNOVATIVE CLINICAL TRIAL SERVICES Brecht Claerhout, Custodix NV on behalf of the EHR4CR Consortium Electronic Health Records for Clinical Research Re-use of EHR data for optimizing Clinical
More informationBDA WORKSHOP PROGRAMME. HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS December 2013 BRUSSELS, BELGIUM
BDA WORKSHOP HOW TO MATURE EMERGING TECHNOLOGIES INTO COMPANION DIAGNOSTICS 12-13 December 2013 BRUSSELS, BELGIUM PROGRAMME BIOTHERAPY DEVELOPMENT ASSOCIATION Content The Biotherapy Development Association
More informationComments from: Leem (Les entreprises du Médicament)
Submission of comments on 'Guidelines on the formalised risk assessment for ascertaining the appropriate good manufacturing practice for excipients of medicinal products for human use Comments
More informationCreation of a pan-european Paediatric Clinical Trials Network. Heidrun Hildebrand (Bayer) & William Treem (Janssen),
Creation of a pan-european Paediatric Clinical Trials Network Heidrun Hildebrand (Bayer) & William Treem (Janssen), 19.12.2016 IMI webinar Need for public-private collaboration Due to European Regulation,
More informationWaste prevention in Europe. European Environment Agency
Waste prevention in Europe Özgür Saki European Environment Agency The European Environment Agency An EU institution situated in Copenhagen since 1994 Provides the information necessary to enable policy
More informationEU health policy. Strategy for the pharmaceutical industry and biosimilars. Salvatore D'Acunto. DG Research. DG Internal Market. DG Health & Consumers
Strategy for the pharmaceutical industry and biosimilars Salvatore D'Acunto European Commission Enterprise and Industry Directorate-General London, 3 April 2014 EU health policy DG Research R&D, innovation
More informationEU Regulatory Perspective
EU Regulatory Perspective Sensible Guidelines. Fergus Sweeney, Head, Compliance and Inspections, European Medicines Agency An agency of the European Union Disclaimer The views presented in this presentation/these
More informationDRAFT MINUTES OF THE FIRST MANAGEMENT COMMITTEE MEETING OF COST ACTION 718
EUROPEAN COMMISSION RESEARCH DIRECTORATE-GENERAL Political Co-ordination and Strategy COST Brussels, 19 May 2000 ZD/00-062 DRAFT MINUTES OF THE FIRST MANAGEMENT COMMITTEE MEETING OF COST ACTION 718 METEOROLOGICAL
More informationAGENDA MENA-OECD STEERING GROUP MEETING. MENA-OECD Initiative on Governance. 3 May 2010 Paris, France. Website:
AGENDA 3 May 2010 Paris, France MENA-OECD STEERING GROUP MEETING MENA-OECD Initiative on Governance and Investment 2009 MENA-OECD for Development Website: www.oecd.org/mena MENA-OECD STEERING GROUP MEETING
More informationWorkshop EERA Joint Programme on Energy Efficiency in Industrial Processes SINTEF office in Brussels Rue de Trone, 61 Brussels, 16 June 2016
Workshop EERA Joint Programme on Energy Efficiency in Industrial Processes SINTEF office in Brussels Rue de Trone, 61 Brussels, 16 June 2016 Borana Taraj, Project Officer, Research & Innovation, EUA This
More informationWhere next for the European Clinical Trials Directive 2001/20/EC?
ISSN 1369-9407 18 DECEMBER 2008 Where next for the European Clinical Trials Directive 2001/20/EC? The voices of stakeholders were heard in London last October and again this month in Brussels. Changes
More informationON CONCLUSIONS AND RECOMMENDATIONS OF THE MEETING ON THE PROTECTION OF THE ENVIRONMENT OF THE CONFERENCE ON SECURITY AND CO-OPERATION IN EUROPE
REPORT ON CONCLUSIONS AND RECOMMENDATIONS OF THE MEETING ON THE PROTECTION OF THE ENVIRONMENT OF THE CONFERENCE ON SECURITY AND CO-OPERATION IN EUROPE Sofia 1989 - Vienna 1990 The representatives of Austria,
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL ENVIRONMENT Directorate C - Quality of Life, Water & Air
EUROPEAN COMMISSION DIRECTORATE-GENERAL ENVIRONMENT Directorate C - Quality of Life, Water & Air DIRECTORATE-GENERAL INTERNAL MARKET AND SERVICES Directorate C Public Procurement Multi-stakeholder Dialogue
More informationADDRESSING THE ENERGY-WATER NEXUS THROUGH R&D PLANNING AND POLICIES
IEA Committee on Energy Research and Technology EXPERTS GROUP ON R&D PRIORITY-SETTING AND EVALUATION ADDRESSING THE ENERGY-WATER NEXUS THROUGH R&D PLANNING AND POLICIES An event organised under the auspices
More informationEuropean Animal Research Association (EARA) ARSAL Symposium Thursday 23 rd May 2015 Animal Research: Time to Talk
European Animal Research Association (EARA) ARSAL Symposium Thursday 23 rd May 2015 Animal Research: Time to Talk EARA Board 2015 Our Articles of Association specify that the board must maintain a 50%
More informationBelgium, a European leader in clinical trials
Belgium, a European leader in clinical trials An attractive country for clinical trials to test innovative medicines In Europe it is nearly impossible to find other countries with as many clinical trials
More informationANIMAL FEEDING STUDIES AND IN VITRO STUDIES IN GMO RISK ASSESSMENT
ANIMAL FEEDING STUDIES AND IN VITRO STUDIES IN GMO RISK ASSESSMENT Context 2 nd Stakeholder Workshop 19-20 MAY 2014 European Commission, Madou tower, 1 Place Madouplein, Brussels, Belgium DRAFT AGENDA
More informationEU Clinical Trial Regulation A view from the Industry
Conference EU Clinical Trial Regulation EU Clinical Trial Regulation A view from the Industry Judith Creba, Executive Director, EU Regulatory Strategy, Novartis Pharma AG University of Basel, Law Faculty
More informationThe Learning Health System in Europe
The Learning Health System in Europe International conference SEPTEMBER 24 th +25 th, 2015 Brussels, Belgium TRANSFoRm What is the Learning Health System? The concept of a Learning Health System (LHS)
More informationFirst Plenary Session CONVERGING OR DIVERGING MODELS OF HTA IN EUROPE. Jean-Luc Harousseau, MD
First Plenary Session Speaker CONVERGING OR DIVERGING MODELS OF HTA IN EUROPE Jean-Luc Harousseau, MD President and Chairman of the Board Haute Autorité de Santé (HAS) Saint-Denis La Plaine, France HTA
More informationTogether towards an Urban Agenda for the EU
Together towards an Urban Agenda for the EU Nicolaas Beets Dutch Urban Envoy VASAB-conference, Warsaw, Poland, 7 June 2016 What is the Urban Agenda for the EU? The Urban Agenda for the EU (UAEU) is a multi-level
More informationRe : EC Consultation Paper Revision of the variations regulations
Merck Sharp & Dohme (Europe) Inc. Lisette Vromans Clos du Lynx 5 Lynx Binnenhof Regulatory Policy Brussel 1200 Bruxelles EU & Most of World 32 2 776 6211 31 412 66 2755 Fax 31 412 66 2571 e-mail : lisette.vromans@merck.com
More informationWENRA Initiatives Related to New Reactor Designs
WENRA Initiatives Related to New Reactor Designs Dana Drábová State Office for Nuclear Safety Czech Republic We, the heads of the national Nuclear Safety Authorities, members of WENRA, commit ourselves
More informationSPONSORSHIP OPPORTUNITIES
CONFERENCES SPONSORSHIP OPPORTUNITIES International Conference on Biomaterials for Bone Tissue Engineering March 18-19, 2019 Dubai, UAE our DELEGATE is your CLIENT Our Programme 5+ Keynote Sessions Our
More informationEFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ)
EFPIA layperson summary Principles that apply to Clinical Trial Transparency. Antonio Ferrari (Chiesi) & Solange Rohou (AZ) Disclaimer I am an employee of Chiesi Farmaceutici s.p.a (Head of Clinical Safety
More informationHow2Guide for Bioenergy. Ingrid Barnsley, Anselm Eisentraut Southeast Asia regional workshop July 2014, Bangkok, Thailand
How2Guide for Bioenergy Ingrid Barnsley, Anselm Eisentraut Southeast Asia regional workshop 23-24 July 2014, Bangkok, Thailand OECD/IEA 2012 International Energy Agency Founded in 1974 Formed in wake of
More informationThe Learning Health System in Europe
The Learning Health System in Europe International conference SEPTEMBER 24 th +25 th, 2015 Brussels, Belgium TRANSFoRm What is the Learning Health System? The concept of a Learning Health System (LHS)
More informationThis document is a preview generated by EVS
TECHNICAL REPORT RAPPORT TECHNIQUE TECHNISCHER BERICHT CEN/TR 15628 July 2007 ICS 03.100.30 English Version Maintenance - Qualification of Maintenance personnel Maintenance - Qualification du personnel
More informationFederal agency for medicines and health products
Federal agency for medicines and health products The implementation of the EU CT Regulation : Overview of the different projects in progress Greet Musch KCE Symposium, 12 th October 2016 1: Overview of
More informationLet us join hands with PvPI to ensure patient safety ADR Reporting Helpline (Toll Free):
Regional Workshop on "Basics of Pharmacovigilance & Establishment of Pharmacovigilance System in Pharmaceutical Industries - A Way Forward" June 23, 2017 - AIIMS, Rishikesh (10:30 AM to 04:00 PM) Last
More informationAudits PDO/PGI/TSG Examples of Good Practices. Johannes Kern DG SANTE/FVO Unit F4.3
Audits PDO/PGI/TSG Examples of Good Practices Johannes Kern DG SANTE/FVO Unit F4.3 Overview (17) DG SANTE/FVO (5) Background Audits PDO/PGI/TSG (4) Lessons Learned and Good Practices (5) 2 DG Sante Food
More informationThe European Commission s strategy on Corporate Social Responsibility (CSR) : achievements, shortcomings and future challenges
The European Commission s strategy on Corporate Social Responsibility (CSR) 2011-2014: achievements, shortcomings and future challenges Fields marked with * are mandatory. 1 Introduction - Background and
More informationInformation on the Member States requirement for the nomination of a pharmacovigilane (PhV) contact person at national level
19 July 2017 EMA/INS/PhV/445316/2017 Committees and Inspections Information on the Member s requirement for the nomination of a pharmacovigilane (PhV) contact person at national level Based on Pharmacovigilance
More informationEditor : Francoise SCHLEMMER Date : 09/03/2015 IMDRF, March 9 th 2015 REPORT Present : Hans-Heiner Junker Francoise SCHLEMMER
The European Association Medical Devices - Notified Bodies TEAM-NB A.I.S.B.L. Boulevard Frère Orban 35A B 4000 Liège BELGIQUE Tél.: + 32 (0)4 254 55 88 Fax: + 32 (0)4 254 55 89 E-mail: secretary@team-nb.org
More informationTechnical Aspects of Implementation. Alastair Nixon, Chair, EFPIA ectd Focus Group, Director, Submission Standards, GSK
Technical Aspects of Implementation Alastair Nixon, Chair, EFPIA ectd Focus Group, Director, Submission Standards, GSK 1 ectd Demonstrations 2 A shared commitment to adopt ectd Health Authorities and industry
More informationHouse of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data
House of Commons Science and Technology Committee: Inquiry on clinical trials and disclosure of data Evidence submitted by the Medical Research Council, 26 February 2013 Introduction 1. The Medical Research
More information[ ] CEMR: A EUROPE WITH A LOCAL AND REGIONAL DIMENSION!
] CEMR: A EUROPE WITH A LOCAL AND REGIONAL DIMENSION! ] CEMR The Council of European Municipalities and Regions (CEMR) is a non-profit association. It is the broadest association of local and regional
More informationINTRODUCTION AND OBJECTIVES
EVENT NAME LOCATION Approaches to skills anticipation and matching experiences in EU and Eastern Partnership region: labour market and skills Observatories (France); methods for labour market and skills
More informationN E W S L E T T E R 1 DEC E M B E R
welcome welcome welcome welcome welcome welcome welcome wel by project coordinator Dr. Ian Knight Welcome to the first newsletter from the iserv project. This project is about showing the practical operation
More informationDoes the European Clinical Trials Directive really improve clinical trial approval time?
British Journal of Clinical Pharmacology DOI:10.1111/j.1365-2125.2008.03246.x Does the European Clinical Trials Directive really improve clinical trial approval time? Hiddo J. Lambers Heerspink, Daniela
More informationIHF and GS1 working together Implementation in French hospitals
IHF and GS1 working together Implementation in French hospitals Jean-Michel DESCOUTURES, IHF, Resah-idf 27th Global GS1 Healthcare Conference Mexico City, 2015-04-24 1 Agenda PART 1. IHF and GS1 working
More informationMEDICAL DEVICES PROGRAMME
MEDICAL DEVICES PROGRAMME 3-4 October 2017 Medical Devices Symposium, updated 29August 2017, external Page 1 Working Party Margareth Jorvid LSM Group, Sweden (Chair) Michael Kipping MHRA, UK Janine Jamieson
More informationAvailability of human medicinal products in Europe how big is the problem and what can we do?
Availability of human medicinal products in Europe how big is the problem and what can we do? Kristin Raudsepp Director General Estonian State Agency of Medicines The presentation Initiative by the regulators
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems, medical products and innovation Medicines: policy, authorisation and monitoring STAMP 4/24 Record STAMP Commission Expert
More information4-Day Study Tour Injection of biomethane into natural gas grids IEE-project GreenGasGrids
4-day Study Tour, supported by the Intelligent Energy Europe (IEE) program 4-Day Study Tour Injection of biomethane into natural gas grids IEE-project GreenGasGrids 25 th to 28 th June 2012 South Germany
More informationCoordination and Support Action: Enabling platform on medicines adaptive pathways to patients
Coordination and Support Action: Enabling platform on medicines adaptive pathways to patients Solange Rohou (AZ) & Luk Maes (BMS) 17.12.2014 IMI webinar Content Background information CSA project proposal
More informationReusable packaging in Europe: Boosting Business and Closing the Loop
INVITATION The European Association of Beverage Wholesalers (CEGROBB), the Environmental Action Germany (Deutsche Umwelthilfe), the Association of Small and Independent Breweries in Europe (S.I.B.) and
More informationConvention on the Transboundary Effects of Industrial Accidents
Convention on the Transboundary Effects of Industrial Accidents Ninth meeting of the Conference of the Parties Ljubljana, 28 30 November 2016. REPUBLIC OF SLOVENIA MINISTRY OF THE ENVIRONMENT AND SPATIAL
More information